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Abstract Evidence has been emerging to suggest that integrin
could induce growth inhibition in some cell types. Some of the
molecular mechanisms underlying growth arrest have been elu-
cidated. We reported here that overexpression of integrin L1
imposed a growth inhibitory e¡ect on the hepatocellular carci-
noma cell line SMMC-7721, and this phenomenon was mainly
attributed to the cyclin-dependent kinase inhibitor p21CIP1. Fur-
thermore, our ¢ndings suggested that transcription activity of
the p21CIP1 gene could be upregulated in the integrin L1-over-
expressing cells, and possibly controlled by the cis-elements in
the core region of the p21CIP1 promoter.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Integrins are a large family of cell receptors binding to the
components of the extracellular matrix (ECM), which gener-
ally activate growth-promoting signaling pathways, such as
activation of extracellular signal-regulated protein kinase,
the c-Jun NH2-terminal kinase [1,2], and phosphatidylinositol
3P-kinase/protein kinase B [1,3]. However, many studies have
demonstrated that integrins give rise to growth inhibition
rather than growth stimulation [4^6]. It seems to be apparent
from these studies that integrin signaling may play a major
role in negative control of cell growth, which may be lost in
some cancer cells.
A member of the CIP/KIP family, p21CIP1 (here referred to
as p21), the ¢rst cyclin-dependent kinase (CDK) inhibitor to
be identi¢ed [7,8], participates in activation control of various
cyclin/CDK protein kinases [9,10], and subsequently plays an
important role in growth arrest, cellular di¡erentiation, DNA
repair, cell senescence and apoptosis [10,11]. The proximal
region of the p21 promoter containing the Sp1 sites was
shown to be the minimal area for mediating up-regulation
of the p21 gene by various external signals derived from the
milieu, such as p53-dependent DNA damage, transforming
growth factor-L (TGF-L), phorbol ester, okadaic acid, proges-
terone, geranylgeranyltransferase I inhibitor and others [12^
18]. Some factors, such as phospholipase D1/2 [19], lead to
down-regulation of the p21 promoter activity. Meanwhile,
p21 gene expression is also regulated by several transcription
factors of importance for growth inhibition, such as p53,
VDR, RAR, C/EBPKL, STATs, Smads, Sp1/Sp3, AP2/AP4,
Myc/Max, Myc/Miz-1, etc. [16,20^30].
In our previous studies, it had been demonstrated that over-
expression of L1 subunit or K5L1 could inhibit cell prolifer-
ation because of the unoccupied L1-class integrins, or relative
lack of its ligands [31,32]. This phenomenon may be involved
in the CDK inhibitor p21 [32]. Since growth inhibition was
induced in integrin-overexpressing cells, we hypothesized that
interference with p21 expression may be one mechanism by
which integrins can arrest cell growth. We report here that
overexpression of integrin L1 subunit in SMMC-7721 cells
could up-regulate transcription activity of the p21 gene, which
may be controlled by the cis-elements in the core region of the
p21 gene promoter via a certain integrin signaling pathway.
2. Materials and methods
2.1. Cell lines, plasmids and stable transfections
The human hepatic cancer cell line SMMC-7721 was obtained from
the Liver Cancer Institute in Zhongshan Hospital (Shanghai, China).
Mammalian expression vector pcDNA3-K5 was a gift from Dr. Sue E.
Craig (School of Biological Sciences, University of Manchester, Man-
chester, UK). The pcDNA3-L1 plasmid was constructed as described
previously [31]. Stable transfections were performed using Lipofect-
amine1 2000 reagent (Life Technologies, Grand Island, NY, USA)
according to the manufacturer’s instructions as described previously
[32]. Integrin K5- and/or L1-overexpressing cells were designated K5^
7721, L1^7721 and K5L1^7721, respectively. We also selected cells
with di¡erent K5 protein levels such as K5.1 and K5.3, and cells
with di¡erent L1 protein levels such as L1.1 and L1.3. Basic culture
medium consisted of RPMI 1640 medium supplemented with 10% calf
bovine serum, 100 IU/ml penicillin and 100 Wg/ml streptomycin. These
integrin-overexpressing cell lines were maintained in the same medium
as above plus 500 Wg/ml geneticin (Gibco BRL). These cells were
incubated at 37‡C, 5% CO2.
2.2. Survival and growth curves of integrin K5/L1-overexpressing cells
Polyhydroxy-ethylmethacrylate (poly-HEME, Sigma)-coated 96-
well plates were prepared as described previously [33]. Fibronectin
(FN)-coated culture plates were also prepared. Brie£y, 100 Wl FN in
phosphate-bu¡ered saline (PBS; 15 Wg/ml) was added into each well
of 96-well plates. These plates were incubated for 1 h at 37‡C, and
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washed with PBS extensively. Cells were then seeded onto poly-
HEME- or FN-coated plates at a density of 2U104 cells/well in 200
Wl RPMI 1640 medium, and grown for 0, 2, 4, 6 or 8 days, respec-
tively. Meanwhile, an equal amount of fresh medium was added into
wells without cells, as control. For each assay, 20 Wl of MTT was
added, and these plates were maintained in culture for 4 h. Following
incubation, culture medium was discarded and 150 Wl dimethyl sulf-
oxide was added to each well. These plates were vibrated gently for
10 min, which was followed by detection in the universal microplate
reader at 490 nm.
2.3. Semi-quantitative reverse transcription polymerase chain reaction
(RT-PCR)
Total RNAs were isolated using the Trizol system (Watson Bio-
technologies, Shanghai, China) according to the manufacturer’s guide-
lines. RT-PCR was performed to quantify the mRNA level of the p21
gene. (dT)15 primer and AMV-RTase were used for ¢rst strand syn-
thesis. cDNA products (2 Wl) were mixed with Taq DNA polymerase
(SABC, Luoyang, China), 50 pmol/l of each appropriate primer, 200
Wmol/l each dNTP in a reaction bu¡er containing 10 mmol/l Tris^HCl
(pH 8.3), 50 mmol/l KCl, 0.01% (W/V) bovine serum albumin (BSA),
2 mmol/l MgCl2 in a ¢nal volume of 100 Wl. The primer pair for p21
was described previously [34]. Primers for L-actin were also described
[35], which were used as the internal control. The expected product
sizes were as follows: p21, 159 bp; L-actin, 412 bp. The samples were
ampli¢ed for 32 cycles at cyclic temperatures of 94‡C 45 s, 60‡C 45 s,
72‡C 45 s. PCR products were analyzed through 1% agarose gel elec-
trophoresis and following ethidium bromide staining. The band area
of p21 was measured and normalized by that of L-actin, and then the
speci¢c p21 mRNA level was estimated.
2.4. Western blot analyses of integrin L1 subunit and p21
Cells were plated at a density of 5U105 cells/8 ml of medium in
£asks and grown for 24 h. Cultured cells were then harvested with
trypsinization and centrifugation and rinsed twice in ice-cold PBS,
and lysed in 1Usodium dodecyl sulfate (SDS) lysis bu¡er (50 mM
Tris^HCl, pH 6.8, 2% SDS, 10% glycerol, 100 Wg/ml phenylmethyl-
sulfonyl £uoride, 10 Wg/ml leupeptin and 5 mM Na3VO4) for 10 min
on ice. The samples were boiled and clari¢ed by centrifugation at
12 000Ug for 8 min at 4‡C. The supernatants were transferred to a
microcentrifuge tube and stored at 320‡C. Protein lysates were re-
solved by SDS^polyacrylamide gel electrophoresis (PAGE) and trans-
ferred onto polyvinylidene di£uoride membranes. The membranes
were blocked in 5% non-fat dry milk in PBST (PBS+0.05% Tween
20) and incubated with mouse anti-human integrin L1 subunit McAb
(BD Transduction Laboratories, 1:500^1:1000) or rabbit anti-human
p21 polyclonal antibody (Santa Cruz, 1:500) diluted in 5% milk in
PBST overnight at room temperature. Following three washes in
PBST, the blots were incubated with the appropriate horseradish per-
oxidase-conjugated secondary antibody (Calbiochem) diluted in
1:500. Finally, these blots were washed three times in PBST, and
developed by enhanced chemiluminescence (Amersham).
2.5. Flow cytometry analysis for cell membrane surface integrin L1
subunit
Cell surface integrin L1 protein levels were detected as described
previously [31,36]. Brie£y, cells were plated at a density of 1U105
cells/8 ml of medium in £asks and grown for 24 h. They were collected
by detachment with 2 mmol/l EDTA and centrifugation at 300Ug for
5 min, and washed twice with ice-cold PBS. Cells were then blocked
with 1 mg/ml BSA in PBS, and incubated with primary antibody K5-
mAb and L1-mAb against human K5L1 expressed onto the cell plasma
membrane for 1^4 h at 4‡C, and then rinsed twice with PBS. Cells
were incubated with a secondary antibody conjugated with £uorescein
for 1 h at 4‡C, washed twice with PBS, and resuspended in 0.5 ml of
PBS, then analyzed on the FACS (Becton Dickinson). A suspension
of 1U104 cells was analyzed for each sample, and each experiment
was repeated at least twice.
2.6. p21 promoter deletion^luciferase reporter constructs
Human p21 promoter region (1908 bp) was obtained from SMMC-
7721 genomic DNA by PCR with the primer pair Up3/Down1, which
harbored KpnI and HindIII sites at the 5P-end of each primer. PCR
products were digested with the two enzymes and cloned into KpnI
and HindIII sites of pGL3-control (designated pGL3^1908). Based on
pGL3^1908, we used the primer pairs Up2/Down1, Up1/Down1, and
Up0/Down1 to amplify di¡erent length fragments of p21 promoter
with identical 3P-ends. These products were digested with KpnI and
HindIII and cloned back into KpnI and HindIII sites of pGL3-con-
trol, giving pGL3^600, pGL3^287, pGL3^217, respectively. These p21
promoter^luciferase reporter plasmids were incorporated with di¡er-
ent genomic fragments from the human p21 promoter to drive ex-
pression of luciferase. Sequences of primers used in this study were
described previously [37], and are listed below: Down1: 5P-GCC
AAGCTT CCG GCT CCA CAA GGA ACT GA-3P, Up0: 5P-GAC
GGTACC CTG GCC TGC TGG AAC T-3P, Up1: 5P-GAC
GGTACC ACC AAC GCA GGC GAG GGA CT-3P, Up2: 5P-
GAG GGTACC GGT GTC TAG GTG CTC CAG GT-3P, Up3:
5P-GTC GGTACC CGT GGT GGT GGT GAG CTA GA-3P (double
Fig. 1. Survival course of K5 and/or L1 integrin-transfected SMMC-
7721 cells. Cell suspensions of the mock and integrin K5/L1-trans-
fected cells were seeded onto 96-well plates, and cultured for 0, 2, 4,
6 or 8 days. Subsequently, cells were quanti¢ed with the MTT as-
say. The mock cells (Mock) represent the parental SMMC-7721 cells
transfected with empty vector pcDNA3. Other types of cells were
K5^7721 (Alpha 5), L1^7721 (Beta 1) and K5L1^7721 (Alpha5beta1).
A: Cells were seeded onto poly-HEME-coated 96-well plates and
grown for the indicated times. From the 4th day of culture, surviv-
ing cells declined signi¢cantly in L1^7721 and K5L1^7721 cells com-
pared with the mock cells (for one sample, t=4.207, P=0.006). B:
Cells were grown on ¢bronectin-coated 96-well plates. The four cell
types had no statistical di¡erence in growth rate even after day 6.
But on the 8th day, L1^7721 and the mock cells grew more rapidly
than the two others (t=3.204, P=0.008).
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underline, HindIII site; single underline, KpnI site). These constructs
were sequenced and compared with the GenBank database.
2.7. Transient transfections and luciferase assays
SMMC-7721 cells were seeded onto 6-well plates, and grown to
over 90% con£uence. Each p21 promoter deletion^luciferase reporter
construct was co-transfected with pGFP-L-gal plasmid (a gift from
Houyan Song, Department of Molecular Genetics, Shanghai Medical
College, Fudan University, Shanghai, China) using Lipofectamine1
2000 reagent according to the manufacturer’s instructions. Lysates
were harvested at 48 h post transfection. To prepare lysates, cells
were washed twice with ice-cold PBS, and then 300 Wl of 1Uluciferase
cell culture lysis reagent (25 mmol/l Tris-phosphate, 2 mmol/l dithio-
threitol, 2 mmol/l 1,2-diaminocyclohexane-N,N,NP,NP-tetraacetic acid,
10% glycerol, 1% Triton X-100) was added directly to the cells. Cells
were scraped and transferred to a microcentrifuge tube, then centri-
fuged at 14 500Ug for 5 min at 4‡C to pellet insoluble materials. The
supernatants were assayed for luciferase activities in triplicate in a
luminometer. Luciferase activities of cell lysates were measured ac-
cording to the manufacturer’s recommendations (Promega, Madison,
WI, USA). In this assay, each tube contained 20 Wl of lysate and 100
Wl of luciferase assay bu¡er. Luciferase activity of each sample was
normalized by L-gal activity. Transfection e⁄ciency was determined
through the positive cells with green £uorescence from the green £uo-
rescent protein (GFP) under the £uorescent microscope. All luciferase
assays were carried out at least in triplicate, and the experiments were
made repeatedly.
3. Results
3.1. Overexpression of integrin L1 subunit inhibits proliferation
of SMMC-7721
In previous studies, we showed that overexpression of in-
tegrin K5L1 or L1 subunit a¡ects cell growth negatively
[31,32]. To further elucidate the negative e¡ects of integrin
L1 overexpression on cell proliferation, we employed poly-
HEME to block attachment of the cells to the ECM. Two
to four days later, growth inhibitory e¡ects of integrin L1
overexpression were observed in the hepatocellular carcino-
ma-derived SMMC-7721 cells (Fig. 1A). On day 6, growth
of K5L1^7721 and L1^7721 cells was inhibited to near 53%
and 60% of the control level, respectively. Moreover, the great
extent of inhibitory e¡ects even lasted to the 8th day. Never-
theless, these transfectants grew at a similar rate when plated
onto the FN-coated plates, even if these cells were grown for
6 days (Fig. 1B). Thus, these results suggest that the inhibitory
e¡ects of integrin L1 overexpression might be attributed to a
lack of ECM, such as FN.
Fig. 2. mRNA and/or protein levels of the cell cycle regulatory p21
gene were increased in L1^7721 and K5L1^7721 transfectants. A:
Immunoblot assays showed p21 protein level was increased in the
L1^7721 and K5L1^7721 cells. The protein level of L-actin was de-
tected to determine the loading amount in each well in the SDS^
PAGE gel. B: mRNA level of p21 was assessed by RT-PCR, and
normalized by that of L-actin. It was apparent that its mRNA level
was increased in the L1- and K5L1-transfected cells. Here shown are
representative data from three independent experiments (*P6 0.01,
compared with the mock cells). Fig. 2 (Continued).
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3.2. p21 expression levels were increased in the integrin L1
transfectant cells
To investigate whether CDK inhibitor p21 is involved in
growth inhibition induced by integrin L1 overexpression in
SMMC-7721 cells, protein and mRNA levels of p21 were
examined in integrin L1 transfectant cells. A marked induction
of p21 protein and mRNA levels was observed in integrin L1-
overexpressing cells, such as L1^7721 and K5L1^7721. As
shown in Fig. 2A, a signi¢cant increase (two-fold) of p21
protein levels was found in L1^7721 and K5L1^7721 compared
with the mock or K5^7721 cells. Meanwhile, the p21 mRNA
level was also increased in integrin L1-overexpressing cells
(Fig. 2B). Consequently, these ¢ndings implied that p21
gene expression was not only modulated at the post-transla-
tional level, but also regulated at the transcriptional level.
Additionally, we also observed notable induction of another
CDK inhibitor, p27KIP1, in integrin L1-overexpressing cells
[32]. However, only the protein level of p27 was increased in
the integrin L1 transfectants. Therefore, induction of p21 gene
expression could be one of the major reasons for growth in-
hibition in the integrin L1-transfected cells.
3.3. Core region of p21 promoter identi¢ed in SMMC-7721
cells
To determine whether p21 mRNA transcription is mediated
by overexpressing integrin L1 subunit, we did experiments to
clarify whether integrin overexpression could stimulate the
activity of the p21 gene promoter. We ampli¢ed the p21
gene promoter region extending from 31880 to +28 bp by
PCR, and constructed p21 promoter deletion^luciferase re-
porter constructs (Fig. 3A). These plasmids contain di¡erent
fragments of the p21 gene promoter, with pGL3^1908 extend-
ing from 31880 to +28 bp (1908 bp), pGL3^600 from 3578
to +28 bp (606 bp), pGL3^287 from 3259 to +28 bp (287 bp),
pGL3^217 from 3189 to +28 bp (217 bp) (Fig. 3B). To elu-
cidate the core region of the p21 gene promoter, we performed
transient transfections with the promoter deletion^luciferase
reporter constructs in SMMC-7721 cells. The transfection ef-
¢ciency was controlled by the GFP £uorescence of the co-
plasmid pGFP-L-gal (Fig. 4). The p21 gene promoter activity
was evaluated by the use of relative luciferase units, whose
expression was driven by the inserted di¡erent fragments of
the p21 promoter. Among the four constructs, pGL3^1908
containing the region of the p21 promoter between 31880
and +28 bp and pGL3^217 between 3189 and +28 bp were
shown to have stronger luciferase activities compared with
control vector (Fig. 5). However, luciferase activity driven
Fig. 3. Construction diagram of p21 promoter^luciferase reporter
vectors. A: Schematic representation of the human p21 gene pro-
moter. Primers used are indicated as Up3, Up2, Up1, Up0 and
Down1. PCR products from the 5P-£anking region of the p21 gene
were ampli¢ed from the genomic DNA in SMMC-7721 cells. B:
Identi¢cation of p21 promoter deletion^luciferase reporter con-
structs. The four constructs of the p21 promoter region were di-
gested with the same two restriction enzymes KpnI/HindIII and re-
solved by 0.8% agarose gel electrophoresis. pGL3-control was
cleaved 240 bp o¡ by KpnI and HindIII enzymes (arrowhead). The
sizes (bp) of inserts are indicated at the left of lanes. Lane 1,
pGL3^1908; lane 2, pGL3^600; lane 3, pGL3^287; lane 4, pGL3^
217; M, DL-2000 DNA marker (TaKaRa).
Fig. 4. Transient transfection e⁄ciency of the p21 promoter constructs. The constructs of the p21 promoter along with pGFP-L-gal were transi-
ently transfected into the parental SMMC-7721 and its derivatives. The e⁄ciency of transfection was determined by the ratio of GFP-positive
cells to the total in some random visual ¢elds. Samples with more than 30% positive cells were regarded as validly transiently transfected.
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by the di¡erent inserts, either from 3578 to +28 bp or from
3259 to +28 bp, was decreased to some extent. So, some
repressive elements could exist in the p21 gene promoter re-
gion extending from 3578 to 3189 bp, which is consistent
with a previous report [23], and the proximal region (between
3189 and +28 bp) might harbor the core elements that con-
trolled p21 gene expression in hepatic cancer cells.
3.4. Activity of p21 core promoter was increased with
overexpression of integrin L1 subunit
As mentioned above, the p21 mRNA level was increased in
integrin L1-overexpressing L1^7721 and K5L1^7721 cells, and
the proximal region of the p21 gene promoter was responsible
for its expression. So we hypothesized that the important
elements might reside in the proximal region and be regulated
by the integrin L1 overexpression. To investigate this e¡ect of
integrin L1 overexpression on p21 promoter activity, we ex-
amined the luciferase activity of the pGL3^217 construct in
integrin L1 transfectant cells. It was noted that its luciferase
activity was stronger in integrin L1-overexpressing cells than
in cells with a lower level of integrin L1 expression (Fig. 6D).
Meanwhile, we evaluated the luciferase activities driven by
four di¡erent inserts in an integrin L1-overexpressing cell
strain (L1.3). Apparently, luciferase activity from the pGL3^
217 construct was still maintained at higher levels. However,
only the promoter activity of pGL3^287 (from 3259 to +28
bp) was signi¢cantly decreased (Fig. 6E). So it occurred to us
from these hints that p21 promoter activity could be up-regu-
lated in integrin L1-overexpressing cells, which possibly acted
through the proximal region (between 3189 and +28 bp) of
the p21 gene promoter, and that repressive element(s) might
be present in the insert of pGL3^287, especially from 3259 to
3189 bp.
Reportedly, there are several transcription factor binding
sites in the proximal region of the p21 gene promoter. On
the basis of these reports, we employed the GenoMatix
Suite/MatInspector software [38] to analyze the potential
binding sites in this proximal region (between 3189 and
+28 bp). As shown in Fig. 7, there are a variety of binding
sites for Sp1, AP2, AP4, E2F and Myo D. In particular, six
Sp1/Sp3 binding sites existed in this area. As is well known,
Sp1 is a kind of general transcription factor involved in tran-
scription control of many target genes. Moreover, some evi-
dence showed that Sp1 could regulate expression of the down-
stream genes (including p21) responsible for a variety of
cellular processes (growth arrest, cell di¡erentiation) together
with co-activators, such as pRB, Smad, p300/CBP [23,39,40].
So Sp1, along with its co-activator, might be implicated in the
p21 expression induced by integrin L1 overexpression.
4. Discussion
Although at least two structurally distinct, but functionally
related, variants of the p21 gene from discrete promoters in
the p21 locus have been identi¢ed [41], p21 is an important
regulator of cell cycle progression, senescence, and di¡erentia-
tion. Integrin signals are also necessary for cells to regulate
di¡erentiation and proliferation [1]. In this study, we observed
growth inhibition in L1-overexpressing cells in the presence of
poly-HEME, which was released when these cells were grown
on FN-coated plates. So unoccupied integrin K5L1 was sug-
gested to be the reason for the growth inhibition.
Additionally, p21 gene expression was induced by overex-
pression of integrin L1 subunit and relative to growth inhibi-
tion of K5L1^7721 and L1^7721 cells. Actually, except for the
relative lack of integrin^ECM interaction described here,
there are plenty of signals from the cellular microenvironment
to regulate p21 gene expression. For example, genotoxic stress
leads to activation of the tumor suppressor p53 and subse-
quently to induction of p21. Moreover, a number of tran-
scription factors are involved in p21 gene promoter activation.
Recently, experimental evidence has shown that p21 transcrip-
tion could be controlled in a p53-dependent or -independent
manner, such as by TGF-L [12], okadaic acid [13], £avone
[42], and sodium butyrate, which is an inhibitor of histone
deacetylase [43].
Several studies report that there are two positive regions in
the p21 gene promoter extending from 32100 to 31600 bp
and from 3124 to 361 bp, which cooperatively regulated p21
gene promoter activation in HepG2 cells [23]. Moreover, the
activity of the proximal promoter region (from 3119 to +16
bp) is similar to that of the full-length promoter of the p21
gene (between 32330 and +16 bp) in the Caco-2 colon ad-
enocarcinoma cell line [21]. In our study, the two essential
promoter regions were present in the 1.9-kb promoter used,
so the minimal p21 promoter^luciferase reporter construct
pGL3^217 containing the promoter region between 3189
and +28 bp functioned as e⁄ciently as a 1.9-kb p21 promoter
construct. Although this proximal region was covered in the
four constructs used in this research, the luciferase activity
was still decreased in either pGL3^600 or pGL3^287, espe-
cially the latter, in integrin L1-overexpressing cells. So the
repressive elements might be present in these regions, espe-
cially from 3259 to 3189 bp. And the proximal region
(from 3189 to +28 bp) was suggested to be a core region
and responsible for its up-regulation mediated by integrin
L1 overexpression.
How to regulate the p21 gene transcription by overexpres-
sion of integrin L1 subunit? This problem was not well known
yet. We hypothesized that some transcription factors whose
binding sites existed in the core promoter region might be
involved, and these transcription factors may be modulated
Fig. 5. Schematic representation of p21 promoter and activities of
p21 promoter serial deletion constructs. SMMC-7721 cells were
transiently transfected with serial deletion reporter constructs.
pGL3^1908 is a construct containing the full-length sequence of the
p21 promoter region ampli¢ed from the genomic DNA of SMMC-
7721 cells. pGL3-basic (denoted by BASIC) is a ¢re£y luciferase re-
porter vector lacking promoter activity, and pGL3-control (denoted
by Control) plasmid was regarded as a positive control, which con-
tains the SV40 promoter and enhancer. Transient transfections and
luciferase assays were performed twice or in triplicate, and the data
were normalized to the activity of bacterial L-galactosidase and ex-
pressed as meansWS.D. RLU, relative luciferase units; 1908, pGL3^
1908; 606, pGL3^600; 287, pGL3^287; 217, pGL3^217.
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by overexpression of integrin L1 in hepatic cancer cells. As is
well known, p21 gene expression was controlled by various
transcription factors together with some co-activators or co-
repressors, especially Sp1/Sp3 and its co-activators [16,20^25].
This might be an important mechanism by which the p21 gene
expression was induced in integrin L1-overexpressing cells,
and this question remains to be further investigated.
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Fig. 6 Activation of p21 gene promoter was up-regulated in integ-
rin L1-overexpressing cells. The cell surface levels of integrin L1 sub-
unit were consistent with the protein levels detected by Western blot
analysis, and here are shown the surface levels in (A) negative con-
trol (Negative), (B) parental SMMC-7721 cells (SMMC) and (C) in-
tegrin L1-overexpressing cell L1.3. D: The stably integrin K5/L1-
overexpressing cells were transiently transfected with the reporter
vector pGL3^217. Cotransfection of pGFP-L-gal, which contains
GFP and L-gal, was used to monitor the transfection e⁄ciency.
After 48 h in growth medium, cellular extracts were assayed using
1UCCLR. Transient transfections and luciferase assays were per-
formed in triplicate. E: Stably overexpressing cell strain L1.3 was
transiently transfected with the four p21 promoter constructs, BA-
SIC and Control. Data were normalized to the activity of L-galacto-
sidase and are shown as meansWS.D. RLU, relative luciferase
units; 1908, pGL3^1908; 606, pGL3^600; 287, pGL3^287; 217,
pGL3^217.
Fig. 6.
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Fig. 7. Sequence representation of the proximal region of the p21
gene promoter (3189^+28). Some putative binding sites for tran-
scription factors regulating the p21 promoter activation are indi-
cated and underlined. The dotted line represents the mutant binding
site for E2F transcription factor, and +1 indicates the transcription
start site. Inr, initiator.
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